Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways

Cancer Letters

Volumn 356, Issue 2, 2015, Pages 273-280

  Hagland, Hanne R ^a   Søreide, Kjetil ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Butyrate; Colorectal cancer; Diet; Energy metabolism; Microbiota; Mitochondria

Indexed keywords

BUTYRIC ACID;

BACTERIAL STRAIN; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CELL METABOLISM; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; DISEASE COURSE; ENERGY METABOLISM; HUMAN; INFLAMMATION; INTESTINE FLORA; LIFESTYLE; METABOLIC SYNDROME X; METABOLISM; METAGENOMICS; NONHUMAN; OBESITY; SHORT SURVEY; SYMBIOSIS; BODY MASS; COLORECTAL TUMOR; COMPLICATION; DIET; GASTROINTESTINAL TRACT; GLYCOLYSIS; MICROBIOLOGY; MICROFLORA; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; PHYSIOLOGY; RISK FACTOR;

BODY MASS INDEX; CARCINOGENESIS; COLORECTAL NEOPLASMS; DIET; GASTROINTESTINAL TRACT; GLYCOLYSIS; HUMANS; LIFE STYLE; METABOLIC NETWORKS AND PATHWAYS; MICROBIOTA; OBESITY; OXIDATIVE PHOSPHORYLATION; RISK FACTORS;

EID: 84920148330     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.02.026     Document Type: Review

References (111)

1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
2. Ibanez C., Valdes A., Garcia-Canas V., Simo C., Celebier M., Rocamora-Reverte L., Gomez-Martinez A., Herrero M., Castro-Puyana M., Segura-Carretero A., Ibanez E., Ferragut J.A., Cifuentes A. Global foodomics strategy to investigate the health benefits of dietary constituents. J. Chromatogr. A 2012, 1248:139-153.
3. Riscuta G., Dumitrescu R.G. Nutrigenomics: implications for breast and colon cancer prevention. Methods Mol. Biol. 2012, 863:343-358.
4. Liu A.Y., Scherer D., Poole E., Potter J.D., Curtin K., Makar K., Slattery M.L., Caan B.J., Ulrich C.M. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol. Nutr. Food Res. 2013, 57:721-734.
5. Bassett J.K., Severi G., Hodge A.M., Baglietto L., Hopper J.L., English D.R., Giles G.G. Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr. Cancer 2013, 65:659-667.
6. Razzak A.A., Oxentenko A.S., Vierkant R.A., Tillmans L.S., Wang A.H., Weisenberger D.J., Laird P.W., Lynch C.F., Anderson K.E., French A.J., Haile R.W., Harnack L.J., Potter J.D., Slager S.L., Smyrk T.C., Thibodeau S.N., Cerhan J.R., Limburg P.J. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr. Cancer 2012, 64:899-910.
7. Bienertova-Vasku J., Sana J., Slaby O. The role of microRNAs in mitochondria in cancer. Cancer Lett. 2013, 336:1-7.
8. R.K. Naviaux, Metabolic features of the cell danger response, Mitochondrion (2013).
9. Verma M., Khoury M.J., Ioannidis J.P. Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidem. Biomark. Prevent. 2013, 22:189-200.
10. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., Leonard P., Li J., Burgdorf K., Grarup N., Jorgensen T., Brandslund I., Nielsen H.B., Juncker A.S., Bertalan M., Levenez F., Pons N., Rasmussen S., Sunagawa S., Tap J., Tims S., Zoetendal E.G., Brunak S., Clement K., Dore J., Kleerebezem M., Kristiansen K., Renault P., Sicheritz-Ponten T., de Vos W.M., Zucker J.D., Raes J., Hansen T., Bork P., Wang J., Ehrlich S.D., Pedersen O., Guedon E., Delorme C., Layec S., Khaci G., van de Guchte M., Vandemeulebrouck G., Jamet A., Dervyn R., Sanchez N., Maguin E., Haimet F., Winogradski Y., Cultrone A., Leclerc M., Juste C., Blottiere H., Pelletier E., LePaslier D., Artiguenave F., Bruls T., Weissenbach J., Turner K., Parkhill J., Antolin M., Manichanh C., Casellas F., Boruel N., Varela E., Torrejon A., Guarner F., Denariaz G., Derrien M., van Hylckama Vlieg J.E., Veiga P., Oozeer R., Knol J., Rescigno M., Brechot C., M'Rini C., Merieux A., Yamada T. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546.
11. Faith J.J., Guruge J.L., Charbonneau M., Subramanian S., Seedorf H., Goodman A.L., Clemente J.C., Knight R., Heath A.C., Leibel R.L., Rosenbaum M., Gordon J.I. The long-term stability of the human gut microbiota. Science 2013, 341:1237439.
12. Peery A.F., Dellon E.S., Lund J., Crockett S.D., McGowan C.E., Bulsiewicz W.J., Gangarosa L.M., Thiny M.T., Stizenberg K., Morgan D.R., Ringel Y., Kim H.P., Dibonaventura M.D., Carroll C.F., Allen J.K., Cook S.F., Sandler R.S., Kappelman M.D., Shaheen N.J. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012, 143:1179-1187. e1173.
13. Siegel R., DeSantis C., Virgo K., Stein K., Mariotto A., Smith T., Cooper D., Gansler T., Lerro C., Fedewa S., Lin C., Leach C., Cannady R.S., Cho H., Scoppa S., Hachey M., Kirch R., Jemal A., Ward E. Cancer treatment and survivorship statistics, 2012. CA Cancer J. Clin. 2012, 62(2012):220-241.
14. Soerjomataram I., Lortet-Tieulent J., Parkin D.M., Ferlay J., Mathers C., Forman D., Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 2008, 380(2012):1840-1850.
15. Bretthauer M. Colorectal cancer screening. J. Intern. Med. 2011, 270:87-98.
16. Herbst A., Kolligs F.T. Detection of DNA hypermethylation in remote media of patients with colorectal cancer: new biomarkers for colorectal carcinoma. Tumour Biol. 2012, 33:297-305.
17. Søreide K., Janssen E.A., Soiland H., Korner H., Baak J.P. Microsatellite instability in colorectal cancer. Br. J. Surg. 2006, 93:395-406.
18. Søreide K., Nedrebø B.S., Knapp J.C., Glomsaker T.B., Søreide J.A., Kørner H. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. Surg. Oncol. 2009, 18:31-50.
19. Cunningham D., Atkin W., Lenz H.J., Lynch H.T., Minsky B., Nordlinger B., Starling N. Colorectal cancer. Lancet 2010, 375:1030-1047.
20. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 2003, 21:1174-1179.
21. Cunningham J.M., Christensen E.R., Tester D.J., Kim C.Y., Roche P.C., Burgart L.J., Thibodeau S.N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998, 58:3455-3460.
22. Thibodeau S.N., French A.J., Cunningham J.M., Tester D., Burgart L.J., Roche P.C., McDonnell S.K., Schaid D.J., Vockley C.W., Michels V.V., Farr G.H., O'Connell M.J. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998, 58:1713-1718.
23. Yu M., Trobridge P., Wang Y., Kanngurn S., Morris S.M., Knoblaugh S., Grady W.M. Inactivation of TGF-beta signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene 2013, 5:5-55.
24. Angstadt A.Y., Berg A., Zhu J., Miller P., Hartman T.J., Lesko S.M., Muscat J.E., Lazarus P., Gallagher C.J. The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk. Cancer 2013, 119:2477-2485.
25. Jacobs R.J., Voorneveld P.W., Kodach L.L., Hardwick J.C. Cholesterol metabolism and colorectal cancers. Curr. Opin. Pharmacol. 2012, 12:690-695.
26. Labadie J., Goodman M., Thyagarajan B., Gross M., Sun Y., Fedirko V., Bostick R.M. Associations of oxidative balance-related exposures with incident, sporadic colorectal adenoma according to antioxidant enzyme genotypes. Ann. Epidemiol. 2013, 23:223-226.
27. Parekh N., Lin Y., Vadiveloo M., Hayes R.B., Lu-Yao G.L. Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the framingham heart study-offspring cohort (1971-2008). Cancer Epidemiol. Biomark. Prevent. 2013, 22:1825-1836.
28. Andersen N.N., Jess T. Has the risk of colorectal cancer in inflammatory bowel disease decreased?. World J. Gastroenterol. 2013, 19:7561-7568.
29. Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2013.
30. Hughes L.A., Simons C.C., van den Brandt P.A., Goldbohm R.A., de Goeij A.F., de Bruine A.P., van Engeland M., Weijenberg M.P. Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). PLoS ONE 2011, 6:e18571.
31. Frankel S., Gunnell D.J., Peters T.J., Maynard M., Davey G. Smith, Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. BMJ 1998, 316:499-504.
32. Svensson E., Grotmol T., Hoff G., Langmark F., Norstein J., Tretli S. Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis. Eur. J. Cancer Prev. 2002, 11:489-495.
33. Svensson E., Moller B., Tretli S., Barlow L., Engholm G., Pukkala E., Rahu M., Tryggvadottir L., Langmark F., Grotmol T. Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia. Cancer Causes Control 2005, 16:215-223.
34. Hughes L.A., van den Brandt P.A., de Bruine A.P., Wouters K.A., Hulsmans S., Spiertz A., Goldbohm R.A., de Goeij A.F., Herman J.G., Weijenberg M.P., van Engeland M. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PLoS ONE 2009, 4:e7951.
35. Speakman J.R., Mitchell S.E. Caloric restriction. Mol. Aspects Med. 2011, 32:159-221.
36. Lee J.V., Shah S.A., Wellen K.E. Obesity, cancer, and acetyl-CoA metabolism. Drug Discov. Today Dis. Mech. 2013, 10:e55-e61.
37. Hughes L.A., van den Brandt P.A., Goldbohm R.A., de Goeij A.F., de Bruine A.P., van Engeland M., Weijenberg M.P. Childhood and adolescent energy restriction and subsequent colorectal cancer risk: results from the Netherlands Cohort Study. Int. J. Epidemiol. 2010, 39:1333-1344.
38. Hughes L.A., Williamson E.J., van Engeland M., Jenkins M.A., Giles G.G., Hopper J.L., Southey M.C., Young J.P., Buchanan D.D., Walsh M.D., van den Brandt P.A., Alexandra Goldbohm R., Weijenberg M.P., English D.R. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int. J. Epidemiol. 2012, 41:1060-1072.
39. Weijenberg M.P., Hughes L.A., Bours M.J., Simons C.C., van Engeland M., van den Brandt P.A. The mTOR pathway and the role of energy balance throughout life in colorectal cancer etiology and prognosis: unravelling mechanisms through a multidimensional molecular epidemiologic approach. Curr. Nutr. Rep. 2013, 2:19-26.
40. Hagland H.R., Berg M., Jolma I.W., Carlsen A., Soreide K. Molecular pathways and cellular metabolism in colorectal cancer. Dig. Surg. 2013, 30:12-25.
41. Morikawa T., Kuchiba A., Lochhead P., Nishihara R., Yamauchi M., Imamura Y., Liao X., Qian Z.R., Ng K., Chan A.T., Meyerhardt J.A., Giovannucci E., Fuchs C.S., Ogino S. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with beta-catenin (CTNNB1) status. Cancer Res. 2013, 73:1600-1610.
42. Ogino S., Nishihara R., Lochhead P., Imamura Y., Kuchiba A., Morikawa T., Yamauchi M., Liao X., Qian Z.R., Sun R., Sato K., Kirkner G.J., Wang M., Spiegelman D., Meyerhardt J.A., Schernhammer E.S., Chan A.T., Giovannucci E., Fuchs C.S. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J. Natl. Cancer Inst. 2013, 105:130-140.
43. Ogino S., King E.E., Beck A.H., Sherman M.E., Milner D.A., Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am. J. Epidemiol. 2012, 176:659-667.
44. Ogino S., Lochhead P., Chan A.T., Nishihara R., Cho E., Wolpin B.M., Meyerhardt J.A., Meissner A., Schernhammer E.S., Fuchs C.S., Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod. Pathol. 2013, 26:465-484.
45. Bardou M., Barkun A.N., Martel M. Obesity and colorectal cancer. Gut 2013, 62:933-947.
46. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977, 31:107-133.
47. Turnbaugh P.J., Gordon J.I. The core gut microbiome, energy balance and obesity. J. Physiol. 2009, 587:4153-4158.
48. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., Stobberingh E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
49. Biasucci G., Benenati B., Morelli L., Bessi E., Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J. Nutr. 2008, 138:1796S-1800S.
50. Liao Y., Jiang R., Lonnerdal B. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life. Biochem. Cell Biol. 2012, 90:476-484.
51. Martin R., Langa S., Reviriego C., Jiminez E., Marin M.L., Xaus J., Fernandez L., Rodriguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. J. Pediatr. 2003, 143:754-758.
52. Azcarate-Peril M.A., Sikes M., Bruno-Barcena J.M. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G401-424.
53. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., Marchesi J.R., Falush D., Dinan T., Fitzgerald G., Stanton C., van Sinderen D., O'Connor M., Harnedy N., O'Connor K., Henry C., O'Mahony D., Fitzgerald A.P., Shanahan F., Twomey C., Hill C., Ross R.P., O'Toole P.W. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. USA 2011, 108(Suppl 1):4586-4591.
54. Claesson M.J., O'Sullivan O., Wang Q., Nikkila J., Marchesi J.R., Smidt H., de Vos W.M., Ross R.P., O'Toole P.W. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS ONE 2009, 4:e6669.
55. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., Mende D.R., Li J., Xu J., Li S., Li D., Cao J., Wang B., Liang H., Zheng H., Xie Y., Tap J., Lepage P., Bertalan M., Batto J.M., Hansen T., Le Paslier D., Linneberg A., Nielsen H.B., Pelletier E., Renault P., Sicheritz-Ponten T., Turner K., Zhu H., Yu C., Li S., Jian M., Zhou Y., Li Y., Zhang X., Li S., Qin N., Yang H., Wang J., Brunak S., Dore J., Guarner F., Kristiansen K., Pedersen O., Parkhill J., Weissenbach J., Meta H.I.T.C., Bork P., Ehrlich S.D., Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
56. Tap J., Mondot S., Levenez F., Pelletier E., Caron C., Furet J.P., Ugarte E., Munoz-Tamayo R., Paslier D.L., Nalin R., Dore J., Leclerc M. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 2009, 11:2574-2584.
57. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., Egholm M., Henrissat B., Heath A.C., Knight R., Gordon J.I. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
58. Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology 2009, 392:1-10.
59. Warren J.R. Helicobacter: the ease and difficulty of a new discovery (Nobel lecture). ChemMedChem 2006, 1:672-685.
60. Tjalsma H., Boleij A., Marchesi J.R., Dutilh B.E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 2012, 10:575-582.
61. Søreide K. Impact of microbial infections on human epigenome and carcinogenesis. Handbook of Epidegentics - The New Molecular and Medical Genetics 2011, 477-494. Academic Press, New York. T. Tollefsbol (Ed.).
62. Collins D., Hogan A.M., Winter D.C. Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2011, 12:504-512.
63. Søreide K. Bacterial genotoxins, gene methylation, and RNA interference: pointing to colorectal cancer as an infectious disease?. Scand. J. Gastroenterol. 2008, 43:1529-1533.
64. Boleij A., Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. Camb. Philos. Soc. 2012, 87:701-730.
65. Buc E., Dubois D., Sauvanet P., Raisch J., Delmas J., Darfeuille-Michaud A., Pezet D., Bonnet R. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 2013, 8:e56964.
66. Dutilh B.E., Backus L., van Hijum S.A., Tjalsma H. Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer. Best Pract. Res. Clin. Gastroenterol. 2013, 27:85-99.
67. Jobin C. Colorectal cancer: CRC-all about microbial products and barrier function?. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:694-696.
68. Human Microbiome Project Consortium A framework for human microbiome research. Nature 2012, 486:215-221.
69. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
70. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
71. Kurokawa K., Itoh T., Kuwahara T., Oshima K., Toh H., Toyoda A., Takami H., Morita H., Sharma V.K., Srivastava T.P., Taylor T.D., Noguchi H., Mori H., Ogura Y., Ehrlich D.S., Itoh K., Takagi T., Sakaki Y., Hayashi T., Hattori M. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 2007, 14:169-181.
72. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
73. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., Heath A.C., Warner B., Reeder J., Kuczynski J., Caporaso J.G., Lozupone C.A., Lauber C., Clemente J.C., Knights D., Knight R., Gordon J.I. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
74. Sobhani I., Amiot A., Le Baleur Y., Levy M., Auriault M.L., Van Nhieu J.T., Delchier J.C. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?. Ther. Adv. Gastroenterol. 2013, 6:215-229.
75. Hullar M.A., Burnett-Hartman A.N., Lampe J.W. Gut microbes, diet, and cancer. Cancer Treat. Res. 2014, 159:377-399.
76. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
77. Donohoe D.R., Wali A., Brylawski B.P., Bultman S.J. Microbial regulation of glucose metabolism and cell-cycle progression in mammalian colonocytes. PLoS ONE 2012, 7:e46589.
78. Wong J.M., de Souza R., Kendall C.W., Emam A., Jenkins D.J. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 2006, 40:235-243.
79. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. J. Appl. Bacteriol. 1992, 72:57-64.
80. Topping D.L., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 2001, 81:1031-1064.
81. Zhu Y., Michelle Luo T., Jobin C., Young H.A. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett. 2011, 309:119-127.
82. O'Keefe S.J., Ou J., Aufreiter S., O'Connor D., Sharma S., Sepulveda J., Fukuwatari T., Shibata K., Mawhinney T. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J. Nutr. 2009, 139:2044-2048.
83. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., Bertalan M., Borruel N., Casellas F., Fernandez L., Gautier L., Hansen T., Hattori M., Hayashi T., Kleerebezem M., Kurokawa K., Leclerc M., Levenez F., Manichanh C., Nielsen H.B., Nielsen T., Pons N., Poulain J., Qin J., Sicheritz-Ponten T., Tims S., Torrents D., Ugarte E., Zoetendal E.G., Wang J., Guarner F., Pedersen O., de Vos W.M., Brunak S., Dore J., Antolin M., Artiguenave F., Blottiere H.M., Almeida M., Brechot C., Cara C., Chervaux C., Cultrone A., Delorme C., Denariaz G., Dervyn R., Foerstner K.U., Friss C., van de Guchte M., Guedon E., Haimet F., Huber W., van Hylckama-Vlieg J., Jamet A., Juste C., Kaci G., Knol J., Lakhdari O., Layec S., Le Roux K., Maguin E., Merieux A., Melo Minardi R., M'Rini C., Muller J., Oozeer R., Parkhill J., Renault P., Rescigno M., Sanchez N., Sunagawa S., Torrejon A., Turner K., Vandemeulebrouck G., Varela E., Winogradsky Y., Zeller G., Weissenbach J., Ehrlich S.D., Bork P. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
84. Castellarin M., Warren R.L., Freeman J.D., Dreolini L., Krzywinski M., Strauss J., Barnes R., Watson P., Allen-Vercoe E., Moore R.A., Holt R.A. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012, 22:299-306.
85. Kostic A.D., Gevers D., Pedamallu C.S., Michaud M., Duke F., Earl A.M., Ojesina A.I., Jung J., Bass A.J., Tabernero J., Baselga J., Liu C., Shivdasani R.A., Ogino S., Birren B.W., Huttenhower C., Garrett W.S., Meyerson M. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22:292-298.
86. Marchesi J.R., Dutilh B.E., Hall N., Peters W.H., Roelofs R., Boleij A., Tjalsma H. Towards the human colorectal cancer microbiome. PLoS ONE 2011, 6:e20447.
87. Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 1927, 8:519-530.
88. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
89. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007, 274:1393-1418.
90. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21:297-308.
91. Hanahan D., Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
92. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., McCormick L.L., Fitzgerald P., Chi H., Munger J., Green D.R. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35:871-882.
93. Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., Tsukamoto T., Rojas C.J., Slusher B.S., Zhang H., Zimmerman L.J., Liebler D.C., Slebos R.J., Lorkiewicz P.K., Higashi R.M., Fan T.W., Dang C.V. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012, 15:110-121.
94. Hu J., Locasale J.W., Bielas J.H., O'Sullivan J., Sheahan K., Cantley L.C., Vander Heiden M.G., Vitkup D. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat. Biotechnol. 2013, 31:522-529.
95. Berg M., Søreide K. EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy. Discov. Med. 2012, 14:207-214.
96. Parsons D.W., Wang T.L., Samuels Y., Bardelli A., Cummins J.M., DeLong L., Silliman N., Ptak J., Szabo S., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B., Lengauer C., Velculescu V.E. Colorectal cancer: mutations in a signalling pathway. Nature 2005, 436:792.
97. Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., Zhuang H., Cinalli R.M., Alavi A., Rudin C.M., Thompson C.B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64:3892-3899.
98. Mailloux R.J., Adjeitey C.N., Harper M.E. Genipin-induced inhibition of uncoupling protein-2 sensitizes drug-resistant cancer cells to cytotoxic agents. PLoS ONE 2010, 5:e13289.
99. Buzzai M., Bauer D.E., Jones R.G., Deberardinis R.J., Hatzivassiliou G., Elstrom R.L., Thompson C.B. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005, 24:4165-4173.
100. DeBerardinis R.J., Thompson C.B. Cellular metabolism and disease: what do metabolic outliers teach us?. Cell 2012, 148:1132-1144.
101. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
102. Berg M., Søreide K. Genetic and epigenetic traits as biomarkers in colorectal cancer. Int. J. Mol. Sci. 2011, 12:9426-9439.
103. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
104. Lunt S.Y., Vander Heiden M.G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 2011, 27:441-464.
105. Burgess D.J. Metabolism: warburg behind the butyrate paradox?. Nat. Rev. Cancer 2012, 12:798.
106. Donohoe D.R., Collins L.B., Wali A., Bigler R., Sun W., Bultman S.J. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 2012, 48:612-626.
107. Andriamihaja M., Chaumontet C., Tome D., Blachier F. Butyrate metabolism in human colon carcinoma cells: implications concerning its growth-inhibitory effect. J. Cell. Physiol. 2009, 218:58-65.
108. Monteleone F., Rosa R., Vitale M., D'Ambrosio C., Succoio M., Formisano L., Nappi L., Romano M.F., Scaloni A., Tortora G., Bianco R., Zambrano N. Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody. Proteomics 2013, 13:866-877.
109. Leschelle X., Delpal S., Goubern M., Blottiere H.M., Blachier F. Butyrate metabolism upstream and downstream acetyl-CoA synthesis and growth control of human colon carcinoma cells. Eur. J. Biochem. 2000, 267:6435-6442.
110. Mazzarelli P., Pucci S., Bonanno E., Sesti F., Calvani M., Spagnoli L.G. Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation?. Cancer Biol. Ther. 2007, 6:1606-1613.
111. Sanders M.E., Guarner F., Guerrant R., Holt P.R., Quigley E.M., Sartor R.B., Sherman P.M., Mayer E.A. An update on the use and investigation of probiotics in health and disease. Gut 2013, 62:787-796.